Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Nocion Therapeutics, Inc. See All Filings	D	2026-03-13 15:50:18 UTC
Amount To Be Raised $22,999,999 Associated Brokers / Dealers N/A CIK Number 0001841279 Filed Document 0001841279-26-000003 Exclusions or Exemptions 506b Accepted Date 2026-03-13 15:50:18 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Nocion Therapeutics, Inc. See All Filings	D	2024-03-13 11:06:17 UTC
Amount To Be Raised $70,044,380 Associated Brokers / Dealers N/A CIK Number 0001841279 Filed Document 0001841279-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-03-13 11:06:17 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Nocion Therapeutics, Inc. See All Filings	D/A	2022-08-24 16:31:03 UTC
Amount To Be Raised $16,999,993 Associated Brokers / Dealers N/A CIK Number 0001841279 Filed Document 0001841279-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-08-24 16:31:03 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Nocion Therapeutics, Inc. See All Filings	D	2021-08-31 13:27:31 UTC
Amount To Be Raised $16,999,993 Associated Brokers / Dealers N/A CIK Number 0001841279 Filed Document 0001841279-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-08-31 13:27:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Nocion Therapeutics, Inc. See All Filings	D	2021-01-22 15:09:15 UTC
Amount To Be Raised $24,999,994 Associated Brokers / Dealers N/A CIK Number 0001841279 Filed Document 0001841279-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-01-22 15:09:15 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity